Market News

Follow the latest financial and economic news, market updates, reports, and analysis on PipVero.

Source: Seeking Alpha News Agency
1 month ago
Stock Medium Importance
Bombardier: Buy As Deleveraging Turns Into Value Creation

Bombardier: Buy As Deleveraging Turns Into Value Creation

Bombardier maintains a buy rating, driven by robust Q2 results and improved financial flexibility. Q2 saw revenue up 6% to $2.15B, adjusted EBITDA up 9%, and free cash flow of $228M despite lower deliveries, with backlog rising to $21.8B. BDRAF's balance sheet strength enables investments in output, Services, Defense, and potential M&A, while net leverage declined to 1.6x.

Related Symbols 1
BOMBF BOMBF
Source: Seeking Alpha
Visit Source
Official Partner ITBFX Start Trading
0 0 0
Read More
Comment
Source: Newsfile Corp News Agency
1 month ago
Stock Medium Importance
PLAB DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Photronics Investors of Securities Class Action Lawsuit Deadline on September 4, 2026

PLAB DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Photronics Investors of Securities Class Action Lawsuit Deadline on September 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Photronics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Photronics between December 10, 2025 and May 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 4, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Photronics, Inc. ("Photronics" or the "Company") (NASDAQ: PLAB) and reminds investors of the September 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Related Symbols 1
PLAB PLAB
Source: Newsfile Corp
Visit Source
0 0 0
Read More
Comment
Source: Newsfile Corp News Agency
1 month ago
Stock Medium Importance
NNOX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

NNOX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nano-X To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nano-X between March 31, 2025 and April 17, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 4, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nano-X Imaging Ltd.

Related Symbols 1
NNOX NNOX
Source: Newsfile Corp
Visit Source
0 0 0
Read More
Comment
Source: Newsfile Corp News Agency
1 month ago
Stock Medium Importance
ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ADMA Biologics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in ADMA Biologics between August 9, 2024 and March 25, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 4, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ADMA Biologics, Inc. ("ADMA Biologics" or the "Company") (NASDAQ: ADMA) and reminds investors of the August 10, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Related Symbols 1
ADMA ADMA
Source: Newsfile Corp
Visit Source
Official Partner ITBFX Start Trading
0 0 0
Read More
Comment